Dermapharm Holding SE (ETR:DMP)

Market Cap	2.12B
Revenue (ttm)	1.20B
Net Income (ttm)	113.79M
Shares Out	53.84M
EPS (ttm)	2.11
PE Ratio	18.62
Forward PE	16.73
Dividend	0.90 (2.28%)
Ex-Dividend Date	Jun 27, 2025

Volume	4,910
Average Volume	17,373
Open	39.45
Previous Close	39.35
Day's Range	39.40 - 40.00
52-Week Range	30.15 - 42.50
Beta	1.31
RSI	61.51
Earnings Date	May 15, 2025

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as product...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 3,610
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DMP

Financial Performance

In 2024, Dermapharm Holding SE's revenue was 1.20 billion, an increase of 3.89% compared to the previous year's 1.15 billion. Earnings were 113.79 million, an increase of 82.44%.